An inhaled steroid improves markers of airway inflammation in patients with mild asthma.

@article{Jatakanon1998AnIS,
  title={An inhaled steroid improves markers of airway inflammation in patients with mild asthma.},
  author={A. Jatakanon and S. Lim and K. Chung and P. Barnes},
  journal={The European respiratory journal},
  year={1998},
  volume={12 5},
  pages={
          1084-8
        }
}
  • A. Jatakanon, S. Lim, +1 author P. Barnes
  • Published 1998
  • Medicine
  • The European respiratory journal
  • Airway inflammation can be demonstrated in mildly asthmatic patients who are not treated with inhaled steroids. Current guidelines recommend that inhaled steroids should be introduced in mild asthmatics who use an inhaled beta2-agonist more than once daily. It was postulated that inhaled steroids can have anti-inflammatory effects in patients with even milder disease. The effect of 4 weeks of treatment with budesonide (800 microg twice daily by Turbohaler) was studied in 10 steroid-naive mildly… CONTINUE READING
    Clinical aspects of exhaled nitric oxide.
    • 231
    • PDF

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 30 REFERENCES
    Efficacy and Safety of Inhaled Corticosteroids in Asthma
    • 458
    Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma.
    • 695
    Use of induced sputum cell counts to investigate airway inflammation in asthma.
    • 900
    • PDF
    Mucosal inflammation in asthma.
    • 1,259